封面
市场调查报告书
商品编码
1198377

智能药盒和药瓶市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Smart Pills Boxes and Bottles Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内(2023 年至 2028 年),智能药盒和药瓶市场预计将以 6.1% 左右的复合年增长率增长。

製药公司是受 COVID-19 疫情直接影响的行业之一。 全球供应链中的缺口很大,包括对药品、活性药物成分、医疗用品和设备的采购、获取和分销的影响。 在大流行的早期阶段,与临床医生对话和患者支持的传统方法可能不再有效,导致製药公司在这场危机中面临灾难性障碍,包括销售损失。 在当前 COVID-19 流行的情况下,远程医疗的需求量很大。 纽约市纪念斯隆凯特琳癌症中心 (MSKCC) 分子影像治疗服务放射科主任 Heiko Schoder 说,2020 年 5 月,我们所有的护理服务、初诊和復诊都过渡到了远程医疗。 这样做是为了通过最大限度地减少患者和医生之间的直接接触来限制冠状病毒的传播。

推动市场增长的因素包括对个性化医疗和微创手术的需求不断增长、慢性病和人口老龄化负担日益加重,以及技术进步。 多种疾病,主要是心血管疾病、传染病、糖尿病和肾臟相关并发症,在世界范围内患病率很高。 因此,各个年龄段的各种疾病的患病率和全球负担不断增加,正在推动对智能医疗技术及其市场的需求。

在全球范围内,癌症是导致死亡的主要原因之一。 该疾病在过去几十年中经历了显着增长,预计在预测期内将稳步增长。 全球癌症观察站估计,2020 年英国将有 457,960 例新确诊癌症病例和 179,648 例癌症死亡病例。

根据英国心臟基金会于 2021 年 7 月发布的一份名为“英国概况”的报告,英国有 760 万人患有心臟和循环系统疾病。 同一份文件还报告说,心臟和循环系统疾病每年在英国造成超过 160,000 人死亡,占该地区所有死亡人数的四分之一。 此外,几种生活方式疾病负担的增加也有望推动市场。 产品发布也是推动市场增长的因素之一。 例如,2020 年 11 月,Pill Connect(前身为 Elucid mHealth)与连续创业者 Jonathan Milner、Catapult Ventures 和 Shallcross Partners 联手在美国和欧洲商业推出电子智能药瓶。510,000 英镑(约合 9000 万美元)日元)的资金收到。

智能药盒和药瓶市场趋势

长期护理机构有望在智能药盒和药瓶市场占据重要份额

长期护理机构是为残障人士和老年患者提供一系列医疗和护理服务的医疗保健中心。 对长期护理的需求通常是严重的持续健康疾病或残疾的结果。 长期护理需求可能会突然出现,例如在心脏病发作或中风之后。

世界上慢性病患病率上升和老年人口不断增加需要多种治疗方案并使用智能药盒和瓶子使消费更容易,所研究的市场是每个细分市场背后的主要推动力 根据世界人口老龄化报告,美国65岁及以上人口预计到2030年将达到7084万,高于2019年的5334万,占比将从2019年的16.2%上升到2030年的20.3% ,表明对市场的潜在积极影响。

老年人通常容易患骨关节炎、慢性阻塞性肺病、糖尿病、抑郁症和痴呆症。 根据阿尔茨海默氏症协会的数据,2020 年美国约有 580 万 65 岁以上的人患有阿尔茨海默氏病,预计到 2050 年这一数字将达到约 1380 万。

此外,专注于开发技术先进的智能药盒的市场参与者正在推动全球市场。 AdhereTech 是一家初创公司,专门为老年护理设施和长期护理设施开发智能无线药瓶。

北美有望主导智能药盒和药瓶市场

北美主导市场主要是因为其先进的研发设施,主要位于美国和加拿大。 各种慢性病患病率上升也推动了该地区的市场增长。

在美国,癌症患者的数量正在显着增加。 美国癌症协会估计,到 2021 年,美国将有 1,898,160 例新诊断的癌症和 608,570 例癌症死亡。

根据美国心脏病学会的数据,死于心血管疾病 (CVD) 的人数正在稳步上升,约占全球所有死亡人数的三分之一,其中 2019 年男性死亡人数约为 960 万,男性死亡人数约为 890 万有妇女死亡的报导。 美国是 2019 年报告死亡人数最多的国家之一。 据联合国报告,2015年美国65岁及以上人口有46986人,到2020年将达到55049人。 预计美国的老龄化速度将快于其他发达国家。 由于这些因素,未来市场可能会扩大。

智能药盒和药瓶市场竞争者分析

智能药盒和药瓶市场竞争激烈,由几家主要参与者组成。 e-pill Medication Reminders、Group Medical Supply LLC、Medipense Inc.、Medminder Inc.、MedReady、PharmRight Corporation、PillDrill Inc. 和 Pillo Inc 等公司占据了相当大的市场份额。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病和人口老龄化负担加重
    • 技术进步
  • 市场製约因素
    • 高成本问题
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分(基于价值的市场规模:百万美元)

  • 按产品类型
    • 智能药盒
    • 智能药瓶
  • 根据指示
    • 痴呆症
    • 癌症管理
    • 糖尿病治疗
    • 其他
  • 最终用户
    • 家庭护理
    • 长期护理机构
    • 医院
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 世界其他地区

第六章竞争格局

  • 公司简介
    • e-pill Medication Reminders
    • Group Medical Supply LLC
    • Medipense Inc.
    • Medminder Inc.
    • MedReady
    • PharmRight Corporation
    • PillDrill Inc.
    • Pillo Inc.
    • Koninklijke Philips NV
    • Pill Connect
    • AdhereTech

第7章 市场机会今后动向

简介目录
Product Code: 69912

The Smart Pills Boxes and Bottles market studied is anticipated to witness a CAGR of nearly 6.1% during the forecast period (2023 - 2028).

Pharmaceutical companies are also among the industries that the COVID-19 outbreak has directly impacted. Gaps in the global supply chain, like an impact on the sourcing, acquisition, and distribution of pharmaceutical products, APIs, medical supplies, and equipment were substantial. Traditional methods of interacting with clinicians and supporting patients were longer viable during the initial phase of the pandemic, which resulted in pharmaceutical companies facing potentially catastrophic barriers, such as lower sales, during this time of crisis. In the current scenario with COVID-19, telemedicine is in high demand. According to Heiko Schoder, Chief of Molecular Imaging And Therapy Service, Department Of Radiology in Memorial Sloan Kettering Cancer Center (MSKCC), New York, in May 2020, their therapy operations, initial consultations, and all follow up consultations were shifted to telemedicine. This was done to minimize the direct contact between patients and doctors, thus controlling the spread of the coronavirus.

Certain factors that are driving the market growth include rising demand for personalized medicine and minimally invasive procedures, the growing burden of chronic disorders and the geriatric population, and technological advancements. The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and the burden globally drive the demand for smart medical technologies and their market.

Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow well over the forecast period. According to the estimates of the Global Cancer Observatory, in 2020, there were an estimated 457,960 new cancer cases diagnosed and 179,648 cancer deaths in the United Kingdom.

According to the British Heart Foundation's Report titled UK Factsheet published in July 2021, there were 7.6 million people in the United Kingdom living with heart and circulatory diseases. Also, the same source reported that in the United Kingdom, heart and circulatory diseases cause more than 160,000 deaths each year, which is a quarter of all deaths in the region. Additionally, the increased burden of several lifestyle disorders is also expected to drive the market. Product launches are another factor in the growth of the market. For instance, in November 2020, Pill Connect, earlier known as Elucid mHealth, received GBP 510,000 funding from serial entrepreneur Jonathan Milner, Catapult Ventures, and Shallcross Partners for the commercial launch of its electronic smart pill bottle in the United States and Europe.

Smart Pills Boxes & Bottles Market Trends

Long-term Care Centers Expected to Hold Significant Share in the Smart Pills Boxes and Bottles Market

Long-term care facilities are the healthcare centers that provide a variety of services, including both medical and personal care, to people who are unable to live independently and for geriatric patients. People frequently need long-term care when they have a severe, continuing health ailment or disability. The necessity for long-term care can arise suddenly, such as after a heart attack or stroke.

The growing prevalence of chronic diseases, coupled with the increasing geriatric population globally, is the major factor driving the respective segment in the market studied as they require multiple treatment regimens, which will be easier to consume with the smart pill boxes and bottles. As per the World Population Ageing Report, in the United States, the number of people above 65 years of age is projected to reach 70.84 million by 2030 from 53.34 million in 2019, and the 65-and-older age group's share in the total population may rise from 16.2% in 2019 to 20.3%, by 2030, showing a positive impact on the market.

The older population is often susceptible to osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, and dementia. As per the data of the Alzheimer's Association, in 2020, about 5.8 million people aged 65 years and above are suffering from Alzheimer's dementia in the United States, and this number is expected to reach around 13.8 million in 2050.

Market players focusing on developing technologically advanced smart pill boxes are also driving the market globally. AdhereTech is a startup specially involved in developing smart wireless pill bottles for senior assisted living and long-term care centers.

North America Expected to Dominate the Smart Pills Boxes and Bottles Market

North America dominates the market primarily due to the advanced research and development facilities, mainly across the United States and Canada. The rising prevalence of various chronic conditions is also fueling the market growth across the region.

The United States has witnessed a considerable rise in the number of cancer patients. According to the estimates of the American Cancer Society, in 2021, there were an estimated 1,898,160 new cancer cases diagnosed and 608,570 cancer deaths in the United States.

As per the American College of Cardiology, the number of people dying from cardiovascular disease (CVD) is steadily rising, which includes around one-third of all deaths globally, of which around 9.6 million deaths were reported among men, and 8.9 million deaths were reported among women in 2019. The United States was among one the countries to report the highest number of deaths in 2019. According to a United Nations report, there were 55,049 people aged 65 years and above in 2020 compared to 46,986 people in 2015 in the United States. The United States is expected to experience an accelerated rate of the aging population as compared to other developed countries. Due to these factors, the market is likely to grow in the future.

Smart Pills Boxes & Bottles Market Competitor Analysis

The Smart Pills Boxes and Bottles market is competitive and consists of a few major players. Companies like e-pill Medication Reminders, Group Medical Supply LLC, Medipense Inc., Medminder Inc., MedReady, PharmRight Corporation, PillDrill Inc., and Pillo Inc. hold substantial market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Disorders and Geriatric Population
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Smart Pill Boxes
    • 5.1.2 Smart Pill Bottles
  • 5.2 By Indication
    • 5.2.1 Dementia
    • 5.2.2 Cancer Management
    • 5.2.3 Diabetes Care
    • 5.2.4 Other Indications
  • 5.3 By End User
    • 5.3.1 Home Care Settings
    • 5.3.2 Long Term Care Centers
    • 5.3.3 Hospitals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 e-pill Medication Reminders
    • 6.1.2 Group Medical Supply LLC
    • 6.1.3 Medipense Inc.
    • 6.1.4 Medminder Inc.
    • 6.1.5 MedReady
    • 6.1.6 PharmRight Corporation
    • 6.1.7 PillDrill Inc.
    • 6.1.8 Pillo Inc.
    • 6.1.9 Koninklijke Philips NV
    • 6.1.10 Pill Connect
    • 6.1.11 AdhereTech

7 MARKET OPPORTUNITIES AND FUTURE TRENDS